Impact of UGT2B17 gene deletion on the steroid profile of an athlete
Open Access
- 15 December 2015
- journal article
- research article
- Published by Wiley in Physiological Reports
- Vol. 3 (12) , e12645
Abstract
The measurement of the testosterone to epitestosterone ratio (T/E ratio) in urine is often used as a marker for testosterone administration in the doping control field. This study examines the frequencies of the different expression forms of the UGT2B17 gene, and assesses their effects on this marker in volunteer subjects. The sample for this descriptive study was composed of male and female athletes aged between 16 and 55 years old who practiced different sports disciplines. All participants underwent a sports‐medical physical examination, and subsequently provided 10 urine samples consecutively over a period of 48 h. The dependent variable examined was T/E and the main independent variable was the UGT2B17 gene polymorphism. During 1 year, 1410 urine samples were obtained from 141 athletes. The frequencies of the three genotypes were as follows: wt homozygotes (ins/ins) 48.2% (n = 68), mutant homozygotes (del/del) 12.1% (n = 17), and heterozygotes (ins/del) 39.7% (n = 56). Genotype distributions varied significantly (P < 0.001) according to ethnicity, 80% of Asian subjects being homozygous for the gene deletion (del/del) compared to 6.9% of Caucasian subjects. A multivariate analysis adjusted for genotype, age, sex, and sports discipline revealed that athletes with the del/del polymorphism showed a significantly lower mean T/E than heterozygotes (ins/del). In contrast, homozygous athletes for the gene insertion (ins/ins) showed higher mean T/E ratios than heterozygotes (ins/del). UGT2B17 gene deletion has a strong influence on the T/E ratio in urine, which is the most efficient indicator of testosterone prohormone misuse. Others factors studied seem not to have such an impact. The genotyping of UGT2B17 is an important source of information for understanding steroid profiling in the doping control field; therefore it is suggested that it be included in the Athletes Biological Passport.Keywords
Funding Information
- Spanish Ministry of Science and Innovation (DEP2009-14788-C03-01/02/03)
This publication has 14 references indexed in Scilit:
- Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypesEuropean Journal of Clinical Investigation, 2013
- The Athlete Biological PassportClinical Chemistry, 2011
- Population based evaluation of a multi-parametric steroid profiling on administered endogenous steroids in single low doseSteroids, 2010
- Quantification of testosterone and metabolites released after alkaline treatment in human urineDrug Testing and Analysis, 2010
- Steroid profiles of professional soccer players: an international comparative studyBritish Journal of Sports Medicine, 2009
- Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping testsSteroids, 2009
- Doping Test Results Dependent on Genotype of Uridine Diphospho-Glucuronosyl Transferase 2B17, the Major Enzyme for Testosterone GlucuronidationThe Journal of Clinical Endocrinology & Metabolism, 2008
- The UGT2B17 gene deletion polymorphism and risk of prostate cancerCancer Detection Prevention, 2007
- Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratioBiostatistics, 2006
- Large Differences in Testosterone Excretion in Korean and Swedish Men Are Strongly Associated with a UDP-Glucuronosyl Transferase 2B17 PolymorphismThe Journal of Clinical Endocrinology & Metabolism, 2006